Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypertension, Pulmonary clinical trials
2 of 11 indexed Hypertension, Pulmonary trials are currently recruiting.
11 US clinical trials · 2 currently recruiting
Hypertension, Pulmonary is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Richard Moon, running 1 of these trials.
The research picture
Hypertension, Pulmonary has 11 registered US clinical trials, 2 of them open to new participants right now, about 18% of the total.
- 2
- recruiting participants now
- 18%
- of trials open to enrollment
- 3
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Richard Moon
Active & Recent Trials
11 total, page 1 of 1
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
Eko Devices
NCT07087613
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Merck Sharp & Dohme
NCT06814145
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ U
NCT04945460
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Actelion
NCT04175600
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
Third Pole Therapeutics
NCT05867914
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Bayer
NCT02576002
Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
Eli Lilly and Company
NCT00549302
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Stanford University
NCT01516398
Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude
Richard Moon
NCT02024386
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Carelon Research
NCT00872170
Dietary Nitrate for Heart Failure
Washington University School of Medicine
NCT01682356
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Hypertension, Pulmonary Trial Landscape
11 indexed Hypertension, Pulmonary studies · 2 recruiting (18%).
Phase mix: 3 late (III/IV) vs 4 early (I/II).
Top sponsor: Richard Moon (1 trial), 9 others listed. 11 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Hypertension, Pulmonary?
PlainTrial tracks 11 US clinical trials for Hypertension, Pulmonary, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Hypertension, Pulmonary?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.